DDW reports on some key news releases that emerged out of this year’s SLAS Europe.  

Cenevo reinforces agentic AI approach with new AI-assistant  

Announced at SLAS Europe, lab management specialist Cenevo launched a new AI-enabled capability for its agentic AI platform Mosaic.  

The company’s Mosaic AI Inventory Search enables scientists to search inventory using natural language, in the hope that it can make sample discovery faster and more intuitive. The function’s AI capabilities lets scientific teams turn inventory data into action without losing traceability, control or context. Teams can describe in plain language what they’re looking for and the AI assistant automatically builds and executes the appropriate search. 

Unlike generic AI chat tools, Mosaic AI Inventory Search is integrated into Mosaic’s sample-centric data model. The assistant understands sample properties, labware types, modalities and customer-specific configurations, enabling more accurate and context-aware search results. 

“Mosaic AI Inventory Search is another step toward connected, agentic labs where AI helps scientific teams move from data to action more seamlessly,” said Alan Parkin, Vice President Product – Mosaic. “By embedding AI directly within trusted laboratory systems, we can deliver faster, more intuitive workflows while maintaining the governance, traceability and control modern labs require.” 

Collaborative Drug Discovery partners with Lily Tunelab to incorporate AI/ML models 

Collaborative Drug Discovery (CDD)  has partnered with Eli Lilly and Company to incorporate the organisation’s collaborative AI/ML drug discovery platform into its CDD Vault platform.  

Lilly TuneLab is Eli Lilly’s AI/ML platform that was created to accelerate biotech innovation by enabling participating companies to access models trained on decades of Lilly’s proprietary research data. 

The agreement between CDD and Lilly will see biotech companies that use CDD Vault able to utilise select Lilly predictive models within their natural scientific workflows. It also paves the way for the planned integration of Lilly Tunelab in both the core and AI modules within CDD Vault.  

“By integrating TuneLab directly into CDD Vault, we are advancing CDD’s core vision to enable collaboration across drug discovery teams and organisations. We believe that solving the most complex challenges in drug discovery will depend on innovative collaboration models that provide broad access to research data and empower chemists and biologists to make informed, data-driven decisions,” said Barry Bunin, CDD Chief Executive Officer and President. “TuneLab’s ADMET models will fit in our trusted secure CDD Vault software environment in natural workflows for experimental and computational scientists and with our growing CDD Vault ecosystem of biopharmaceutical companies.” 

Bionomous launches automated platform for complex biological models  

Swiss-based start-up Bionomous launched its new Sortivo platform at SLAS Europe. The device automates the screening, sorting and plating of complex biological entities from 300µm to ~2mm such as zebrafish embryos and organoids, workflows that, until now, have relied on hours of manual pipetting under a stereomicroscope. 

Sortivo integrates high-resolution brightfield and multi-channel fluorescence imaging with AI classification and gentle handling in a compact benchtop system. By combining the capabilities of image-based picking and large-particle sorting, Sortivo offers the same individualised, large-scale screening for large and delicate entities that flow cytometry provided for single cells. 

With regulators actively encouraging the adoption of New Approach Methodologies (NAMs), the company is hoping that Sortivo can increase the adoption of Zebrafish embryos and organoids, whose adoption at scale has been limited by manual, labour intensive workflows.  

By automating those workflows, Sortivo helps academic, pharma and CRO labs translate the promise of NAMs into routine, reproducible experiments. 

Frank Bonnet, CEO and Co-Founder of Bionomous, said: “Sortivo represents the next step in our mission to automate and accelerate life science research. Our customers told us very clearly: zebrafish and organoid workflows have outgrown manual sorting. They need a platform that combines gentle handling with image-based AI and standardised plating, and that they can actually afford and operate every week. Sortivo is our answer.” 

Hamilton and Cerillo partner on automation and microplate capabilities  

Hamilton will utilise its expertise in liquid handling and automation with Cerillo’s compact microplate reader technology in a collaboration announced at SLAS Europe.  

The companies state that the partnership will strengthen both organisations’ ability to deliver seamless, end-to-end detection and analysis solutions for modern laboratory workflow. 

Cerillo will bring its expertise in delivering high-performance microplate readers to Hamilton’s liquid handling and automation platforms. The companies state the partnership and integration of technologies will enable them to offer more tightly integrated solutions that combine precision liquid handling with advanced detection, enabling researchers to streamline workflows without compromising performance or reliability. 

Through the partnership, the companies hope to better serve the rapidly growing microbiome research, synthetic biology, and environmental microbiology markets. 

The post News round-up from SLAS Europe   appeared first on Drug Discovery World (DDW).